Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Efficacy and safety of artemisinin-based combination therapies for the treatment of uncomplicated malaria in pediatrics: a systematic review and meta-analysis

Fig. 3

Meta-analysis of day 42 efficacy of artemisinin combination therapy administration (PR: DerSimonian-larid random-effects untransformed proportion).Abbreviations:- C.I.: confidence interval, n: events, N: total in the per-protocol analysis, DP: dihydroartemisinin-piperaquine, CDA: Chlorproguanil-dapsone-artesunate, AL: artemether-lumefantrine, AP: artesunate-pyronaridine

Back to article page
\